Cutaneous manifestations after COVID-19 vaccination are recorded and reported by researchers.
Mechanisms of postinflammatory hyperpigmentation (PIH) and postinflammatory erythema (PIE) may be closer to being identified.
A prospective, case-control study examines the effectiveness of antioxidants in treating lichen planus.
Researchers aimed to compare the efficacy of QR678 Neo® plus intralesional steroid therapy vs intralesional steroid therapy alone for alopecia areata.
Treatment of tinea capitis in children with a novel dose of itraconazole is reported.
The safety and efficacy of ustekinumab was determined in a phase 2 trial for the treatment of recurrent oral ulcers in Behçet disease.
The National Institute for Health and Care Excellence (NICE) provides updated recommendations for managing acne, including both the physical manifestations of the disease as well as its psychological affect.
Colorimeter and point counting technique as objective methods for monitoring changes in vitiligo lesions during treatment with Nb-UVB are assessed.
Ligelizumab is a high-affinity monoclonal anti-immunoglobulin E antibody.
Current, evidence-based recommendations for the management of cutaneous lupus erythematosus (CLE) in the presence or absence of systemic lupus erythematosus (SLE) in adults, young people, and children are provided.